Drug intelligence / Profile preview

carbon-13

Development stage
Unknown
Lead developer
Cliniques universitaires Saint-Luc
Modality
Small Molecules
Administration
Oral
01

Overview

C13-Cliniques universitaires Saint-Luc- Université Catholique de Louvain refers to a Carbon-13 (13C) labeled diagnostic tracer used in a functional ureogenesis test developed by the Cliniques universitaires Saint-Luc. Carbon-13 is a stable, non-radioactive isotope of carbon. In this diagnostic application, a 13C-labeled substrate—typically sodium acetate—is administered orally to subjects. The tracer enters the metabolic pathways of the urea cycle, where it is incorporated into urea. By measuring the appearance of 13C-labeled urea in the blood or the elimination of labeled byproducts, clinicians can quantitatively assess the in vivo functional capacity of the urea cycle. This test is primarily investigated as a tool for diagnosing and monitoring patients with urea cycle disorders (UCDs), providing a dynamic measure of metabolic flux that traditional static ammonia or amino acid measurements may not capture.

Other names
Carbon-13Carbon13Carbon 1313C-labeled tracer[13C]sodium acetateC13-labeled substrateC-13-labeled substrateC 13-labeled substrate
02

Targets

TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on carbon-13.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on carbon-13.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call